| 摘要 |
medicine, pharmacy. SUBSTANCE: pharmaceutical coposition has tumor necrosis alpha-factor, hyaluronic acid, dimethylsulfoxide and polyethylene oxide in the following ratio of components, wt.-%: tumor necrosis alpha-factor, 0.001-0.01; hyaluronic acid, 0.1-1.0; dimethylsulfoxide, 5.0-15.0 and polyethylene oxide, the balance. Composition is used for treatment of infection-inflammatory diseases, among them in complex therapy of acute and chronic gynecological inflammatory diseases, in complex therapy of herpetic and other viral infections, in treatment of urogenital infections and in treatment of sluggish wounds. EFFECT: enhanced therapeutic effectiveness, broadened spectrum of use. 1 cl, 2 tbl, 8 ex |
